PROCESS FOR CLONING DIFFERENTIALLY EXPRESSED GENES

Information

• Research Project
• 3498763

• ApplicationId

  3498763

• Core Project Number

  R43GM047215

• Full Project Number

  1R43GM047215-01A1

• Serial Number

  47215

• FOA Number

• Sub Project Id

• Project Start Date

  9/1/1992 - 33 years ago

• Project End Date

  4/30/1993 - 33 years ago

• Program Officer Name

• Budget Start Date

  9/1/1992 - 33 years ago

• Budget End Date

  4/30/1993 - 33 years ago

• Fiscal Year

  1992

• Support Year

  1

• Suffix

  A1

• Award Notice Date

  8/31/1992 - 33 years ago

Organizations

• NOVAGEN LLC

The proposed research would investigate the feasibility of a method for direct isolation and cloning of genes associated with states of disease, cell differentiation, or metabolic induction. Phase I studies will focus on steps in the process that currently limit the widespread use of substractive nucleic acid hybridization as a means of isolating the target genes. In Phase II this technology will be integrated and optimized to allow the cloning of any gene that is active in one cell type but not another.

IC Name

• Activity

  R43

• Administering IC

  GM

• Application Type

  1

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

  821

• Ed Inst. Type

• Funding ICs

• Funding Mechanism

• Study Section

  SSS

• Study Section Name

• Organization Name

  NOVAGEN, INC.

• Organization Department

• Organization DUNS

• Organization City

  MADISON

• Organization State

  WI

• Organization Country

  UNITED STATES

• Organization Zip Code

  53711

• Organization District

  UNITED STATES